Elsevier to Publish ESCMID’s Flagship Journals

Clinical Microbiology and Infection and NewMicrobes & New Infections to be published by Elsevier effective January2015

London, UK, September 5, 2014

Elsevier, a world-leading provider of scientific, technicaland medical information products and solutions, announced today that an agreement has been reached with the EuropeanSociety of Clinical Microbiology and Infectious Diseases (ESCMID) to publish its flagship journals, ClinicalMicrobiology and Infection (CMI) and NewMicrobes & New Infections(NMNI) beginning January 1, 2015.

"Elsevier and ESCMID havecollaborated on a number of projects over the years and we are delighted tostrengthen our relationship as ESCMID's publishing partner for CMI and NMNI," commented Anne Kitson, ExecutiveVice President, Health and Medical Sciences Journals at Elsevier. "We lookforward to working with ESCMID to ensure the continuing success of CMIand to support the editorial team of NMNI as they forge a new, excitingpath within the community."

Established in 1995, CMI is widely recognized as one of thepremier international journals in the field. It is guided by an eminenteditorial board led by Editor-in-Chief Didier Raoult, MD, PhD, Aix-MarseilleUniversity, Marseille, France. The journal publishes peer-reviewed papers thatpresent basic and applied research relevant to therapy and diagnostics in thefields of microbiology, infectious diseases, virology, parasitology, immunologyand epidemiology.

To allow quick publication ofnew events in clinical microbiology and to facilitate data sharing byscientists in the field across the globe, ESCMID launched NMNI in 2013under the leadership of Editor-in-Chief Michel Drancourt, MD, PhD,Aix-Marseille University. It serves the field as a multilingual, peer-reviewed,open access journal for rapid dissemination of the latest research, with aparticular focus on new genomes, new microbes and new technology applied to thediagnosis of infectious and tropical diseases.

Murat Akova, MD, ESCMIDPresident, remarked, "The Society is extremely pleased to enter into this newphase of our relationship with Elsevier. It will enable us to expand the impactand global reach of our publications, which are key information resources inthe professional lives of microbiologists and infectious disease specialists."

---

About ESCMID
ESCMID is a non-profit organization dedicated toimproving the diagnosis, treatment and prevention of infectious diseases inEurope and beyond. The Society promotes and supports research, education andtraining in clinical microbiology and infectious diseases and shares goodmedical practice in both disciplines to build capacity throughout Europe. www.escmid.org

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com

Media contact
Fiona Macnab
Elsevier
+44 20 7424 4259
 F.Macnab@elsevier.com